APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nifedipine Injection Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchNifedipine Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine Injection Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Nifedipine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nifedipine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nifedipine Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nifedipine Injection market include Teva, Medcalo, Mylan, Pfizer, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Bayer, Pharmaoffer and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nifedipine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nifedipine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nifedipine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nifedipine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Nifedipine Injection Segment by Company

Teva

Medcalo

Mylan

Pfizer

Cisen Pharmaceutical

Wuhan Binhu Shuanghe Pharmaceutical

Bayer

Pharmaoffer

AdvaCare

Nifedipine Injection Segment by Type

10mg/2ml

20mg/2ml

Nifedipine Injection Segment by Application

Hypertension

Angina (Chest Pain)

Nifedipine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nifedipine Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nifedipine Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nifedipine Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Nifedipine Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nifedipine Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nifedipine Injection industry.

Chapter 3: Detailed analysis of Nifedipine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nifedipine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nifedipine Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nifedipine Injection Industry Trends Table 2. Nifedipine Injection Industry Drivers Table 3. Nifedipine Injection Industry Opportunities and Challenges Table 4. Nifedipine Injection Industry Restraints Table 5. Global Nifedipine Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nifedipine Injection Revenue Share by Company (2021-2026) Table 7. Global Nifedipine Injection Sales Volume by Company (L) & (2021-2026) Table 8. Global Nifedipine Injection Sales Volume Share by Company (2021-2026) Table 9. Global Nifedipine Injection Average Price (US$/ml) of Company (2021-2026) Table 10. Global Nifedipine Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nifedipine Injection Key Company Manufacturing Base & Headquarters Table 12. Global Nifedipine Injection Company, Product Type & Application Table 13. Global Nifedipine Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nifedipine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg/2ml Table 18. Significant Companies of 20mg/2ml Table 19. Global Nifedipine Injection Sales Volume by Type 2021 VS 2025 VS 2032 (L) Table 20. Global Nifedipine Injection Sales Volume by Type (2021-2026) & (L) Table 21. Global Nifedipine Injection Sales Volume by Type (2027-2032) & (L) Table 22. Global Nifedipine Injection Sales Volume Share by Type (2021-2026) Table 23. Global Nifedipine Injection Sales Volume Share by Type (2027-2032) Table 24. Global Nifedipine Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nifedipine Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nifedipine Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nifedipine Injection Sales Value Share by Type (2021-2026) Table 28. Global Nifedipine Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hypertension Table 30. Significant Companies of Angina (Chest Pain) Table 31. Global Nifedipine Injection Sales Volume by Application 2021 VS 2025 VS 2032 (L) Table 32. Global Nifedipine Injection Sales Volume by Application (2021-2026) & (L) Table 33. Global Nifedipine Injection Sales Volume by Application (2027-2032) & (L) Table 34. Global Nifedipine Injection Sales Volume Share by Application (2021-2026) Table 35. Global Nifedipine Injection Sales Volume Share by Application (2027-2032) Table 36. Global Nifedipine Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Nifedipine Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Nifedipine Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Nifedipine Injection Sales Value Share by Application (2021-2026) Table 40. Global Nifedipine Injection Sales Value Share by Application (2027-2032) Table 41. Global Nifedipine Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Table 42. Global Nifedipine Injection Sales by Region (2021-2026) & (L) Table 43. Global Nifedipine Injection Sales Market Share by Region (2021-2026) Table 44. Global Nifedipine Injection Sales by Region (2027-2032) & (L) Table 45. Global Nifedipine Injection Sales Market Share by Region (2027-2032) Table 46. Global Nifedipine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Nifedipine Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Nifedipine Injection Sales Value Share by Region (2021-2026) Table 49. Global Nifedipine Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Nifedipine Injection Sales Value Share by Region (2027-2032) Table 51. Global Nifedipine Injection Market Average Price (US$/ml) by Region (2021-2026) Table 52. Global Nifedipine Injection Market Average Price (US$/ml) by Region (2027-2032) Table 53. Global Nifedipine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Table 54. Global Nifedipine Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Nifedipine Injection Sales by Country (2021-2026) & (L) Table 56. Global Nifedipine Injection Sales Market Share by Country (2021-2026) Table 57. Global Nifedipine Injection Sales by Country (2027-2032) & (L) Table 58. Global Nifedipine Injection Sales Market Share by Country (2027-2032) Table 59. Global Nifedipine Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Nifedipine Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Nifedipine Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Nifedipine Injection Sales Value Market Share by Country (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 66. Teva Nifedipine Injection Product Portfolio Table 67. Teva Recent Development Table 68. Medcalo Company Information Table 69. Medcalo Business Overview Table 70. Medcalo Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 71. Medcalo Nifedipine Injection Product Portfolio Table 72. Medcalo Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 76. Mylan Nifedipine Injection Product Portfolio Table 77. Mylan Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 81. Pfizer Nifedipine Injection Product Portfolio Table 82. Pfizer Recent Development Table 83. Cisen Pharmaceutical Company Information Table 84. Cisen Pharmaceutical Business Overview Table 85. Cisen Pharmaceutical Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 86. Cisen Pharmaceutical Nifedipine Injection Product Portfolio Table 87. Cisen Pharmaceutical Recent Development Table 88. Wuhan Binhu Shuanghe Pharmaceutical Company Information Table 89. Wuhan Binhu Shuanghe Pharmaceutical Business Overview Table 90. Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 91. Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio Table 92. Wuhan Binhu Shuanghe Pharmaceutical Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 96. Bayer Nifedipine Injection Product Portfolio Table 97. Bayer Recent Development Table 98. Pharmaoffer Company Information Table 99. Pharmaoffer Business Overview Table 100. Pharmaoffer Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 101. Pharmaoffer Nifedipine Injection Product Portfolio Table 102. Pharmaoffer Recent Development Table 103. AdvaCare Company Information Table 104. AdvaCare Business Overview Table 105. AdvaCare Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 106. AdvaCare Nifedipine Injection Product Portfolio Table 107. AdvaCare Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Nifedipine Injection Distributors List Table 111. Nifedipine Injection Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Nifedipine Injection Product Image Figure 2. Global Nifedipine Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nifedipine Injection Sales (2021-2032) & (L) Figure 5. Global Nifedipine Injection Sales Average Price (US$/ml) & (2021-2032) Figure 6. Global Nifedipine Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg/2ml Image Figure 10. 20mg/2ml Image Figure 11. Global Nifedipine Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (L) Figure 12. Global Nifedipine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nifedipine Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Nifedipine Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nifedipine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nifedipine Injection Sales Value Share by Type (2021-2032) Figure 17. Hypertension Image Figure 18. Angina (Chest Pain) Image Figure 19. Global Nifedipine Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (L) Figure 20. Global Nifedipine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Nifedipine Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Nifedipine Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Nifedipine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Nifedipine Injection Sales Value Share by Application (2021-2032) Figure 25. Global Nifedipine Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Figure 26. Global Nifedipine Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Nifedipine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Nifedipine Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Nifedipine Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Nifedipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Nifedipine Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Nifedipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Nifedipine Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Nifedipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Nifedipine Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Nifedipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Nifedipine Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Nifedipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Nifedipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Nifedipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Nifedipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Nifedipine Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Nifedipine Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/2ml
  • 20mg/2ml
Applications
  • Hypertension
  • Angina (Chest Pain)
Companies covered
  • Teva
  • Medcalo
  • Mylan
  • Pfizer
  • Cisen Pharmaceutical
  • Wuhan Binhu Shuanghe Pharmaceutical
  • Bayer
  • Pharmaoffer
  • AdvaCare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nifedipine Injection Sales Value (2021-2032)
  4. 1.2.2 Global Nifedipine Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Nifedipine Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nifedipine Injection Market Dynamics
  1. 2.1 Nifedipine Injection Industry Trends
  2. 2.2 Nifedipine Injection Industry Drivers
  3. 2.3 Nifedipine Injection Industry Opportunities and Challenges
  4. 2.4 Nifedipine Injection Industry Restraints
3 Nifedipine Injection Market by Company
  1. 3.1 Global Nifedipine Injection Company Revenue Ranking in 2025
  2. 3.2 Global Nifedipine Injection Revenue by Company (2021-2026)
  3. 3.3 Global Nifedipine Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Nifedipine Injection Average Price by Company (2021-2026)
  5. 3.5 Global Nifedipine Injection Company Ranking (2024-2026)
  6. 3.6 Global Nifedipine Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Nifedipine Injection Company Product Type and Application
  8. 3.8 Global Nifedipine Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nifedipine Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nifedipine Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nifedipine Injection Market by Type
  1. 4.1 Nifedipine Injection Type Introduction
  2. 4.1.1 10mg/2ml
  3. 4.1.2 20mg/2ml
  4. 4.2 Global Nifedipine Injection Sales Volume by Type
  5. 4.2.1 Global Nifedipine Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nifedipine Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nifedipine Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nifedipine Injection Sales Value by Type
  9. 4.3.1 Global Nifedipine Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nifedipine Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nifedipine Injection Sales Value Share by Type (2021-2032)
5 Nifedipine Injection Market by Application
  1. 5.1 Nifedipine Injection Application Introduction
  2. 5.1.1 Hypertension
  3. 5.1.2 Angina (Chest Pain)
  4. 5.2 Global Nifedipine Injection Sales Volume by Application
  5. 5.2.1 Global Nifedipine Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nifedipine Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Nifedipine Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Nifedipine Injection Sales Value by Application
  9. 5.3.1 Global Nifedipine Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nifedipine Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Nifedipine Injection Sales Value Share by Application (2021-2032)
6 Nifedipine Injection Regional Sales and Value Analysis
  1. 6.1 Global Nifedipine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nifedipine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Nifedipine Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Nifedipine Injection Sales by Region (2027-2032)
  5. 6.3 Global Nifedipine Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nifedipine Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nifedipine Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nifedipine Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Nifedipine Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nifedipine Injection Sales Value (2021-2032)
  12. 6.6.2 North America Nifedipine Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nifedipine Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Nifedipine Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nifedipine Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nifedipine Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nifedipine Injection Sales Value (2021-2032)
  21. 6.9.2 South America Nifedipine Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nifedipine Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nifedipine Injection Sales Value Share by Country, 2025 VS 2032
7 Nifedipine Injection Country-level Sales and Value Analysis
  1. 7.1 Global Nifedipine Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nifedipine Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nifedipine Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Nifedipine Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Nifedipine Injection Sales by Country (2027-2032)
  6. 7.4 Global Nifedipine Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nifedipine Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nifedipine Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nifedipine Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nifedipine Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nifedipine Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nifedipine Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nifedipine Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nifedipine Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nifedipine Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nifedipine Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nifedipine Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nifedipine Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nifedipine Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nifedipine Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nifedipine Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nifedipine Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nifedipine Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nifedipine Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nifedipine Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nifedipine Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nifedipine Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nifedipine Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nifedipine Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nifedipine Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nifedipine Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nifedipine Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nifedipine Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nifedipine Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nifedipine Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nifedipine Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nifedipine Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nifedipine Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Nifedipine Injection Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Medcalo
  8. 8.2.1 Medcalo Company Information
  9. 8.2.2 Medcalo Business Overview
  10. 8.2.3 Medcalo Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medcalo Nifedipine Injection Product Portfolio
  12. 8.2.5 Medcalo Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Nifedipine Injection Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Nifedipine Injection Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Cisen Pharmaceutical
  26. 8.5.1 Cisen Pharmaceutical Company Information
  27. 8.5.2 Cisen Pharmaceutical Business Overview
  28. 8.5.3 Cisen Pharmaceutical Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cisen Pharmaceutical Nifedipine Injection Product Portfolio
  30. 8.5.5 Cisen Pharmaceutical Recent Developments
  31. 8.6 Wuhan Binhu Shuanghe Pharmaceutical
  32. 8.6.1 Wuhan Binhu Shuanghe Pharmaceutical Company Information
  33. 8.6.2 Wuhan Binhu Shuanghe Pharmaceutical Business Overview
  34. 8.6.3 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio
  36. 8.6.5 Wuhan Binhu Shuanghe Pharmaceutical Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Nifedipine Injection Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Pharmaoffer
  44. 8.8.1 Pharmaoffer Company Information
  45. 8.8.2 Pharmaoffer Business Overview
  46. 8.8.3 Pharmaoffer Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pharmaoffer Nifedipine Injection Product Portfolio
  48. 8.8.5 Pharmaoffer Recent Developments
  49. 8.9 AdvaCare
  50. 8.9.1 AdvaCare Company Information
  51. 8.9.2 AdvaCare Business Overview
  52. 8.9.3 AdvaCare Nifedipine Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 AdvaCare Nifedipine Injection Product Portfolio
  54. 8.9.5 AdvaCare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nifedipine Injection Value Chain Analysis
  2. 9.1.1 Nifedipine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nifedipine Injection Sales Mode & Process
  6. 9.2 Nifedipine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nifedipine Injection Distributors
  9. 9.2.3 Nifedipine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst